Stay updated on Eplontersen in ATTR CM: Clinical Trial

Sign up to get notified when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eplontersen in ATTR CM: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:52:32.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to include new information about Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) and the EudraCT number for ION-682884-CS2, while significant details regarding the study's design and inclusion/exclusion criteria have been removed.
    Difference
    14%
    Check dated 2025-04-16T01:47:46.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and removed a date reference of March 25, 2025, while adding a new date of December 27, 2024.
    Difference
    0.4%
    Check dated 2025-04-08T20:27:35.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous version (v2.14.2) and last update date of December 27, 2024.
    Difference
    0.3%
    Check dated 2025-04-01T15:44:19.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-03-03T22:21:43.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:42:03.000Z thumbnail image

Stay in the know with updates to Eplontersen in ATTR CM: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.